Why the study?
Does exogenous adiponectin improve endothelial function and metabolic parameters in Wistar rats fed a high-fat diet?
Does exogenous adiponectin improve endothelial function and metabolic parameters in Wistar rats fed a high-fat diet?
Exogenous adiponectin improves endothelial function and metabolic parameters in rats on a high-fat diet by increasing eNOS phosphorylation and reducing perivascular adipose tissue inflammation.
Answers are grounded in this paper and cite their sources.
Adiponectin effects in obese rats are hypothesis-generating; leaves open translation to human endothelial dysfunction.
BACKGROUND AND PURPOSE: Adiponectin, the most abundant peptide secreted by adipocytes, is involved in the regulation of energy metabolism and vascular physiology. Here, we have investigated the effects of exogenous administration of adiponectin on metabolism, vascular reactivity and perivascular adipose tissue (PVAT) of mesenteric arteries in Wistar rats fed a high-fat diet. EXPERIMENTAL APPROACH: ) was administered by continuous infusion with a minipump, implanted subcutaneously, for 28 days. KEY RESULTS: Chronic adiponectin treatment reduced body weight, total cholesterol, free fatty acids, fasting glucose and area under the curve of intraperitoneal glucose tolerance test, compared with HFD rats. It also normalized NO-dependent vasorelaxation increasing endothelial NO synthase (eNOS) phosphorylation in mesenteric arteries of HFD rats. In PVAT from aged (W12m) and HFD rats there was increased expression of chemokines and pro-inflammatory adipokines, the latter being important contributors to endothelial dysfunction. Infusion of adiponectin reduced these changes. CONCLUSIONS AND IMPLICATIONS: Adiponectin normalized endothelial cell function by a mechanism that involved increased eNOS phoshorylation and decreased PVAT inflammation. Detailed characterization of the adiponectin signalling pathway in the vasculature and perivascular fat is likely to provide novel approaches to the management of atherosclerosis and metabolic disease. LINKED ARTICLES: This article is part of a themed section on Molecular Mechanisms Regulating Perivascular Adipose Tissue - Potential Pharmacological Targets? To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.20/issuetoc.
No takes yet. Share an insight, caveat, or question.
Sena et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: